EyePoint Pharmaceuticals, Inc. 8-K

Accession 0001564590-21-010712

Filing information

CIK: 0001314102
Report date: 2021-03-04
Filing date: 2021-03-04
Form: 8-K
Primary document: eypt-8k_20210304.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.